日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Human macrophages engineered to secrete a bispecific T cell engager support antigen-dependent T cell responses to glioblastoma

人类巨噬细胞经过改造,分泌双特异性 T 细胞接合剂,支持针对胶质母细胞瘤的抗原依赖性 T 细胞反应

Jennifer L Gardell, Lisa R Matsumoto, Harrison Chinn, Kole R DeGolier, Shannon A Kreuser, Brooke Prieskorn, Stephanie Balcaitis, Amira Davis, Richard G Ellenbogen, Courtney A Crane

NKG2D ligand expression in pediatric brain tumors

NKG2D 配体在儿童脑肿瘤中的表达

Kristen Haberthur, Kathryn Brennan, Virginia Hoglund, Stephanie Balcaitis, Harrison Chinn, Amira Davis, Shannon Kreuser, Conrad Winter, Sarah E S Leary, Gail H Deutsch, Richard G Ellenbogen, Courtney A Crane

A non-oncogenic HPV 16 E6/E7 vaccine enhances treatment of HPV expressing tumors

一种非致癌性HPV 16 E6/E7疫苗可增强对表达HPV的肿瘤的治疗效果。

Wieking, B G; Vermeer, D W; Spanos, W C; Lee, K M; Vermeer, P; Lee, W T; Xu, Y; Gabitzsch, E S; Balcaitis, S; Balint, J P Jr; Jones, F R; Lee, J H

Control of SIV infection and subsequent induction of pandemic H1N1 immunity in rhesus macaques using an Ad5 [E1-, E2b-] vector platform

利用Ad5 [E1-, E2b-]载体平台控制恒河猴SIV感染并诱导其对大流行性H1N1病毒的免疫力

Gabitzsch, Elizabeth S; Balint-Junior, Joseph P; Xu, Younong; Balcaitis, Stephanie; Sanders-Beer, Brigitte; Karl, Julie; Weinhold, Kent J; Paessler, Slobodan; Jones, Frank R

An Ad5[E1-, E2b-]-HER2/neu vector induces immune responses and inhibits HER2/neu expressing tumor progression in Ad5 immune mice

Ad5[E1-, E2b-]-HER2/neu 载体可诱导免疫反应并抑制 Ad5 免疫小鼠体内表达 HER2/neu 的肿瘤进展。

Gabitzsch, E S; Xu, Y; Balcaitis, S; Balint, J P Jr; Jones, F R

Induction and comparison of SIV immunity in Ad5 naïve and Ad5 immune non-human primates using an Ad5 [E1-, E2b-] based vaccine

利用基于Ad5 [E1-, E2b-]的疫苗,在未感染过Ad5和已感染过Ad5的非人灵长类动物中诱导和比较SIV免疫力。

Gabitzsch, Elizabeth S; Xu, Younong; Balint, Joseph P Jr; Balcaitis, Stephanie; Sanders-Beer, Brigitte; Jones, Frank R